Medpace Holdings, Inc. (MEDP)
669.20
+15.24
(+2.33%)
USD |
NASDAQ |
Oct 23, 16:00
668.94
-0.26
(-0.04%)
After-Hours: 20:00
Medpace Holdings Price to Book Value : 31.92 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 31.92 |
| October 22, 2026 | 31.19 |
| October 21, 2026 | 31.60 |
| October 20, 2026 | 29.69 |
| October 19, 2026 | 29.55 |
| October 16, 2026 | 29.50 |
| October 15, 2026 | 29.98 |
| October 14, 2026 | 29.41 |
| October 13, 2026 | 29.09 |
| October 12, 2026 | 29.57 |
| October 09, 2026 | 29.19 |
| October 08, 2026 | 28.74 |
| October 07, 2026 | 28.82 |
| October 06, 2026 | 28.75 |
| October 05, 2026 | 29.59 |
| October 02, 2026 | 28.59 |
| October 01, 2026 | 28.52 |
| September 30, 2026 | 29.77 |
| September 29, 2026 | 39.92 |
| September 28, 2026 | 39.53 |
| September 25, 2026 | 39.71 |
| September 24, 2026 | 39.82 |
| September 23, 2026 | 39.60 |
| September 22, 2026 | 40.44 |
| September 21, 2026 | 40.06 |
| Date | Value |
|---|---|
| September 18, 2026 | 39.29 |
| September 17, 2026 | 39.48 |
| September 16, 2026 | 39.56 |
| September 15, 2026 | 39.82 |
| September 14, 2026 | 38.21 |
| September 11, 2026 | 37.70 |
| September 10, 2026 | 37.42 |
| September 09, 2026 | 37.62 |
| September 08, 2026 | 37.92 |
| September 04, 2026 | 37.94 |
| September 03, 2026 | 38.08 |
| September 02, 2026 | 38.05 |
| September 01, 2026 | 37.42 |
| August 31, 2026 | 38.12 |
| August 28, 2026 | 38.54 |
| August 27, 2026 | 39.24 |
| August 26, 2026 | 39.72 |
| August 25, 2026 | 39.40 |
| August 24, 2026 | 39.79 |
| August 21, 2026 | 39.83 |
| August 20, 2026 | 39.31 |
| August 19, 2026 | 39.03 |
| August 18, 2026 | 37.88 |
| August 17, 2026 | 38.32 |
| August 14, 2026 | 37.12 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| IQVIA Holdings, Inc. | 7.451 |
| Champions Oncology, Inc. | 16.88 |
| Avantor, Inc. | 2.078 |
| Personalis, Inc. | 7.169 |
| Adaptive Biotechnologies Corp. | 28.39 |
Price to Book Value Related Metrics
| PE Ratio | 37.10 |
| PS Ratio | 6.770 |
| PEG Ratio | 1.419 |
| Price to Free Cash Flow | 28.78 |
| Price | 669.20 |
| Earnings Yield | 2.70% |
| Market Cap | 18.67B |
| PEGY Ratio | 1.419 |
| Operating PE Ratio | 31.65 |
| Normalized PE Ratio | 37.10 |